Trader Note — 9345 total
Leidos Holdings enters the back half of June under fresh analyst pressure, with a high-profile downgrade landing just as the stock extends a painful two-month slide. BofA Securities cut its rating to Neutral from Buy…
PTF, the Invesco Dorsey Wright Technology Momentum ETF, is navigating a sharp one-day pullback after an impressive weekly run — and the lending market has quietly shifted into a notably tighter configuration over just…
WU enters the week with a rare confluence: short interest at a multi-month high, borrow availability at its tightest level all year, and the stock trading at just $7.26 — down 13% over the past month. The short side of…
XPO heads into the final stretch before July earnings with an unusual tension: short sellers are accumulating at the fastest monthly pace in months, even as the Street keeps marking targets higher. The most striking…
USO — the United States Oil Fund — has had a brutal week, falling 12% to $115.47 and extending a one-month drawdown of 22%, yet the lending market has flashed a surprisingly contradictory signal: availability has…
GameStop enters the week of June 17 with the most persistent options-market defensiveness on record since early 2021 — and the short side is finally starting to move in the same direction. The clearest signal remains…
PSI, the Invesco Semiconductors ETF, has reversed course sharply on both price and positioning — the fund is up nearly 10% on the week, but short sellers have returned at a pace that stands out even against a backdrop…
MORN heads into the final weeks before its July 22 earnings report with a quiet but deliberate build in short interest running against a stock that has already dropped 6.5% on the week — a combination that makes the…
VGK is telling two different stories at once: the price is rising while the cost to borrow is surging, creating a setup worth watching for anyone using this ETF as a European equity hedge. The ETF added 2.4% on the…
HUN just posted its worst single-day drop in recent memory, falling 17% on June 16 to close at $13.18 — and the short sellers who spent the past month quietly rebuilding positions were well positioned for it. Short…
Samsung Electronics has put in one of its strongest monthly runs in years, gaining 27% over the past month and 6.5% in the past week alone — yet its closest correlated peers spent the same week in reverse. The peer…
HSBC has added another 7.5% this week alone, closing at £14.096, and the question the market is now asking is whether the re-rating has moved fast enough to outrun the fundamentals. The valuation shift this week is the…
NOVO B clawed back 4% on the week to DKK 280.30, but the rebound sits inside a month that is still down 6.3% — and the stock's own scoring system keeps flashing a warning that short-term relief does not erase longer…
2330 closes the week at TWD 2,400, up 4.1% over five sessions, and the borrow story that dominated the last two notes has now reversed completely. The defining feature of this week is a dramatic unwind in domestic…
SoftBank Group heads into its June 24 earnings with a recovery story that short sellers are notably unwilling to challenge — a posture worth examining given what the last two prints delivered. The price recovery is the…
LATAM Airlines Group has put in a strong week, but the move looks more like a sector-wide lift than a company-specific catalyst. The stock gained 8.3% over the past week to close at CLP 24.49, extending a 13.7% rally…
GSK is the quiet outperformer in a difficult week for large-cap pharma — up 2.4% while most of its closest peers fell — and the question worth sitting with is whether that relative strength reflects genuine conviction…
LLOY has gained 6% in a week and 10.6% over the past month, joining a broad European banking rally — but the stock's own positioning data suggests the move is driven by genuine re-rating rather than short-covering…
NOKIA closed Tuesday at €12.01, down 4.2% on the day but barely changed on the week — a tentative pause in a correction that has now erased roughly 20% from the late-May peak, with peers falling in tandem and the…
Elevance Health gave back ground this week, falling 6.3% to $397.80 — erasing the gains that had briefly carried the stock above its consensus mean target and putting options traders on edge just four weeks before the…
